Pipeline

Zyngenia has applied its technology to generate a pipeline that is comprised of innovative multi-specific and multi-valent biotherapeutics (Zybodies™) that address well-validated targets. Zyngenia has advanced three programs into preclinical development and achieved preclinical proof-of-concept with both bi-specific and tri-specific Zybodies in cancer and inflammation.

Zyngenia pipeline